Subscribe To

Price Alert Latest News Economic Calendar News

ONTTF / Oxford Nanopore resolves dispute with DHSC

Oxford Nanopore Technologies PLC (LSE:ONT) has reached an amicable resolution to its dispute with the Department of Health and Social Care (DHSC). DHSC and Oxford Nanopore entered into a settlement agreement without any admission of liability, which included a payment of £50mln due to the latter under the terms of a contract to supply certain LamPORE devices and testing kits. Read More

Demo Live Account See Partner Details

Content Topics

Oxford

Nanopore

Resolves

Dispute

With

Dhsc

Stock

ONTTF

Posted: Apr 1 2022, 03:41

Author Name: Proactive Investors

ONTTF News

By Proactive Investors
October 19, 2023

Oxford Nanopore gets £70m investment from French in-vitro diagnostics partner

Oxford Nanopore Technologies PLC (LSE:ONT) has secured a £70 million investment from French in-vitro diagnostics (IVD) company bioMérieux, in exchan

By Proactive Investors
September 6, 2023

Oxford Nanopore tightens guidance, analysts remain sceptical

Oxford Nanopore Technologies PLC (LSE:ONT) analysts are still doubtful about the DNA sequencing company's medium-term guidance despite narrowing fu

By Proactive Investors
May 19, 2023

Oxford Nanopore Technologies hails advances

Oxford Nanopore Technologies PLC (LSE:ONT) has announced significant breakthroughs in its nanopore sequencing technology at the annual London Calling

By Proactive Investors
March 21, 2023

Oxford Nanopore Technologies reports narrowed loss as revenue jumps

Oxford Nanopore Technologies PLC (LSE:ONT) reported a solid increase in full-year revenue driven by growth in its Life Science Research Tools (LSRT) a

By Seeking Alpha
February 8, 2023

Oxford Nanopore: Illumina's Formidable Challenger

Oxford Nanopore is well-positioned to take advantage of the growing demand for DNA sequencing services and capture a growing share of the market. The

By Proactive Investors
June 30, 2022

Oxford Nanopore names former Ocado CFO Duncan Tatton-Brown as non-executive chair

Oxford Nanopore Technologies PLC (LSE:ONT) said it appointed former Ocado Group PLC (LSE:OCDO) chief financial officer Duncan Tatton-Brown as its non-

By Proactive Investors
April 1, 2022

Oxford Nanopore resolves dispute with DHSC

Oxford Nanopore Technologies PLC (LSE:ONT) has reached an amicable resolution to its dispute with the Department of Health and Social Care (DHSC). DHS

By Seeking Alpha
March 22, 2022

Oxford Nanopore Technologies Limited (ONTTF) CEO Gordon Sanghera on Q4 2021 Results - Earnings Call Transcript

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.